OpenAI's GPT Image 2 Is Now Available on Pollo AI
SINGAPORE, April 22, 2026 /PRNewswire/ -- Pollo AI today announced the availability of OpenAI's GPT Image 2 on its platform, giving creators, marketers, and businesses access to a stronger image model for work that depends on getting details right....
Lingnan ICH Shines on the Global Haute Couture Stage: One Heung Kong and Guangdong Fashion Week Forge a New Paradigm for Chinese Original Design
GUANGZHOU, China, April 22, 2026 /PRNewswire/ -- As the global fashion industry undergoes a period of restructuring, Oriental aesthetics have emerged as the cornerstone of international creativity. From April 17 to 24, the 2026 Guangdong Fashion...
FHA - Asia's Premier F&B Trade Show Unites over 2,750 Exhibitors to Shape the Future of Food & Hospitality
Global showcase spanning across 10 Halls with 76 Group Pavilions to showcase 800,000+ F&B innovations, co-locating with ProWine Singapore and IndusFood Asia Diverse Lineup with more than 2750 exhibitors, with 80% international counterparts and...
AscendCare Medical Clinic Launches Public Awareness Initiative to Normalise Regular Health Screening in Singapore
SINGAPORE, April 22, 2026 /PRNewswire/ -- AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe health screenings as a routine and responsible component...
ImmunoForge to Accelerate CNS Drug Development with Innovative BBB Shuttle Platform 'LMT15'
ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first place at 'Novo Nordisk Partnering Day Korea 2026' SEOUL, South Korea, April 22, 2026...
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently...
WATERTECH CHINA 2026 to Spotlight Two High-Impact Forums, Driving Early Pre-Registration from Global Water Professionals
SHANGHAI, April 22, 2026 /PRNewswire/ -- As the global water sector moves toward smarter, greener and more efficient development, WATERTECH CHINA 2026 ,organized by Herui Group, will return from June 9–11, 2026 at the National Exhibition and...
XCMG Hydrogen-Powered Heavy Truck Completes "Hydrogen Marathon" Verification, Advancing Low-Carbon Heavy Transport
XUZHOU, China, April 22, 2026 /PRNewswire/ -- As Earth Day underscores this year's theme, "Our Power, Our Planet," global momentum toward low-carbon transition continues to accelerate. Against this backdrop, XCMG's hydrogen-powered heavy truck has...